| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| E Vancaester, P Santen. Catatonia and neuroleptic malignant syndrome: two sides of a coin? Acta neurologica Belgica. vol 107. issue 2. 2007-09-28. PMID:17710840. |
on the level of pathophysiology however, catatonia and nms are quite different, with catatonia rather being a cortical psychomotor syndrome and nms a subcortical motor disorder. |
2007-09-28 |
2023-08-12 |
Not clear |
| Orson P Rodriguez, Matthew S Dowel. A case report of neuroleptic malignant syndrome without fever in a patient given aripiprazole. The Journal of the Oklahoma State Medical Association. vol 99. issue 7. 2006-11-03. PMID:17017330. |
conditions that share some features of nms but have different treatment regimens include serotonergic syndrome, lethal catatonia, malignant hyperthermia, infections and various heat disorders. |
2006-11-03 |
2023-08-12 |
Not clear |
| G Benjelloun, L Jehel, G Abgrall, A Pelissolo, Jf Allilair. [Acute catatonic syndrome after neuroleptic malignant syndrome]. L'Encephale. vol 31. issue 6 Pt 1. 2006-03-10. PMID:16462690. |
similar clinical and biological features in catatonia and neuroleptic malignant syndrome (nms) suggest a relationship between both affections and common physiopathological mechanisms and neurochemical basis: a central dopamine deficiency. |
2006-03-10 |
2023-08-12 |
Not clear |
| G Benjelloun, L Jehel, G Abgrall, A Pelissolo, Jf Allilair. [Acute catatonic syndrome after neuroleptic malignant syndrome]. L'Encephale. vol 31. issue 6 Pt 1. 2006-03-10. PMID:16462690. |
we believe like many authors that catatonia and nms are two aspects of a same disease, arising the question of chronology of both affections: nms precipitates catatonia evolution. |
2006-03-10 |
2023-08-12 |
Not clear |
| Perminder S Sachde. A rating scale for neuroleptic malignant syndrome. Psychiatry research. vol 135. issue 3. 2005-10-20. PMID:15996751. |
the scale may be applicable not only to nms or suspected nms but also to nms-like syndromes such as lethal catatonia. |
2005-10-20 |
2023-08-12 |
human |
| Alan Hanft, Christopher F Eggleston, James A Bourgeoi. Neuroleptic malignant syndrome in an adolescent after brief exposure to olanzapine. Journal of child and adolescent psychopharmacology. vol 14. issue 3. 2005-02-15. PMID:15650507. |
paranoid psychosis with catatonia was present after recovery from the nms. |
2005-02-15 |
2023-08-12 |
Not clear |
| G Northof. Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology. Journal of neural transmission (Vienna, Austria : 1996). vol 109. issue 12. 2003-04-18. PMID:12486486. |
neuroleptic malignant syndrome (nms), there has been a recent re-emergence in clinical and scientific interest in catatonia. |
2003-04-18 |
2023-08-12 |
Not clear |
| G Northof. Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology. Journal of neural transmission (Vienna, Austria : 1996). vol 109. issue 12. 2003-04-18. PMID:12486486. |
however, exact psychopathological and pathophysiological characterization of both nms and catatonia remains unclear.clinically, catatonia and nms show more or less similar motor symptoms i.e. |
2003-04-18 |
2023-08-12 |
Not clear |
| G Northof. Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology. Journal of neural transmission (Vienna, Austria : 1996). vol 109. issue 12. 2003-04-18. PMID:12486486. |
while in nms the "motor loop" may be dysregulated by neuroleptic blockade of subcortical striatal d-2 receptors one may rather assume cortical gaba-ergic alteration in catatonia. |
2003-04-18 |
2023-08-12 |
Not clear |
| G Northof. Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology. Journal of neural transmission (Vienna, Austria : 1996). vol 109. issue 12. 2003-04-18. PMID:12486486. |
gaba-ergic cortical dysfunction may account for affective and behavioural abnormalities in catatonia which cannot be observed as such in nms. |
2003-04-18 |
2023-08-12 |
Not clear |
| G Northof. Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology. Journal of neural transmission (Vienna, Austria : 1996). vol 109. issue 12. 2003-04-18. PMID:12486486. |
consequently, one may characterize catatonia as a cortical "psychomotor syndrome" while nms may rather be regarded as subcortical "motor syndrome". |
2003-04-18 |
2023-08-12 |
Not clear |
| Domenico Berardi, Maddalena Dell'Atti, Mario Amore, Diana De Ronchi, Giuseppe Ferrar. Clinical risk factors for neuroleptic malignant syndrome. Human psychopharmacology. vol 17. issue 2. 2003-01-17. PMID:12404699. |
our study suggests that a clinical syndrome of acute disorganization, in addition to acute catatonia, is a potential clinical risk factor for nms. |
2003-01-17 |
2023-08-12 |
Not clear |
| D Kasantikul, P Kanchananakhi. Severe catatonia and neuroleptic malignant syndrome: report of 3 cases. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. vol 82. issue 9. 1999-11-30. PMID:10561954. |
we report a patient with severe catatonia and two cases of nms. |
1999-11-30 |
2023-08-12 |
Not clear |
| J W Le. Serum iron in catatonia and neuroleptic malignant syndrome. Biological psychiatry. vol 44. issue 6. 1998-12-28. PMID:9777183. |
preliminary data suggest that decreased serum iron levels predict the progression of catatonia to neuroleptic malignant syndrome (nms). |
1998-12-28 |
2023-08-12 |
Not clear |
| J W Le. Serum iron in catatonia and neuroleptic malignant syndrome. Biological psychiatry. vol 44. issue 6. 1998-12-28. PMID:9777183. |
this study examines the predictive value of low serum iron in this nms conversion and explores other potential significance of serum iron in catatonia. |
1998-12-28 |
2023-08-12 |
Not clear |
| J W Lee, S Robertso. Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 9. issue 3. 1997-12-19. PMID:9339882. |
the use of conventional neuroleptics transformed the excited malignant catatonia into a stuporous state resembling neuroleptic malignant syndrome (nms). |
1997-12-19 |
2023-08-12 |
Not clear |
| J W Lee, S Robertso. Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 9. issue 3. 1997-12-19. PMID:9339882. |
such a transformation of excited lethal catatonia into nms has been described in the literature, providing support for the hypothesis that nms is a variant of catatonia. |
1997-12-19 |
2023-08-12 |
Not clear |
| J W Lee, S Robertso. Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 9. issue 3. 1997-12-19. PMID:9339882. |
opinions, however, have been conflicting whether lethal catatonia and nms are indistinguishable. |
1997-12-19 |
2023-08-12 |
Not clear |
| J W Lee, S Robertso. Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 9. issue 3. 1997-12-19. PMID:9339882. |
we argue that nms may be regarded as a neuroleptic-induced retarded (stuporous) subtype of malignant catatonia, clinically indistinguishable from nonneuroleptic retarded malignant catatonia but different from the excited form. |
1997-12-19 |
2023-08-12 |
Not clear |
| D Blume. Catatonia and the neuroleptics: psychobiologic significance of remote and recent findings. Comprehensive psychiatry. vol 38. issue 4. 1997-08-20. PMID:9202876. |
neuroleptics in fact duplicate or approximate the symptoms of catatonia by producing mental immobilization, hypokinesis (parkinsonism and dystonia), hyperkinesis (akathisia), and pernicious catatonia in the modern guise of the neuroleptic malignant syndrome (nms). |
1997-08-20 |
2023-08-12 |
Not clear |